Private equity firm Advent-backed Bharat Serums and Vaccines (BSV) on Tuesday said it has acquired Tidilan (isoxsuprine hydrochloride), a leading brand in women’s health from Bengaluru-based Jagdale Industries. BSV...
Sanofi clinches $2 billion vaccines deal with Translate Bio
French drugmaker Sanofi has agreed a potential $2 billion vaccines deal with Translate Bio, expanding their collaboration in development of an inoculation against COVID-19 and sending the U.S. biotech company’s shares...
Merck to slim down with asset spinoff, focus on Keytruda, vaccines
Merck & Co Inc said on Wednesday it will spin off its women’s health, biosimilar drugs and older products into a separate publicly traded company as it tightens its focus on growth drivers like cancer drug Keytruda...
Carlyle-Zydus and Advent join race to acquire Bharat Serums and Vaccines Ltd
A consortium of Carlyle and Zydus Cadila is competing with private equity group Advent International to acquire Mumbai-based bio-pharmaceutical company Bharat Serums and Vaccines Ltd. (BSV). The two have submitted non...
Sanofi to buy vaccines biotech group Protein Sciences
French drugmaker and healthcare group Sanofi is to buy privately-held U.S vaccines biotech company Protein Sciences for an initial amount of $650 million, as Sanofi steps up its acquisition program after recently...
Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%
Consumer healthcare firm Haleon said on Monday that U.S. drugmaker Pfizer, its top shareholder, will sell down its stake in the company to about 24%. Pfizer, which currently holds a 32% stake in Haleon, said last year...
ADIA, HarbourVest eye minor stake in Cohance
The Abu Dhabi Investment Authority (ADIA), the sovereign wealth fund of the oil-rich emirate, along with London-based private equity fund HarbourVest, is in discussions to acquire a minority stake in Cohance...
GSK to sell 3.2% stake in spin-off Haleon in its third stake sale in under a year
GSK, opens new tab will sell a 3.2% stake, or about 300 million shares, in its spun-off consumer healthcare business Haleon, opens new tab, the British drugmaker said on Tuesday. The announcement marks the third time...
Thermo Fisher Scientific to buy Olink in $3.1 billion deal
Thermo Fisher Scientific would acquire Olink Holding AB in a deal valued at $3.1 billion, the companies said on Tuesday, as the U.S. medical equipment maker seeks to boost its life sciences portfolio that helps drug...
US-based Advent seeking investors for Suven-Cohance merger
US-based Advent could rope in new investors into its planned combination of Suven Pharma and Cohance Life Sciences, as it looks to create a top three contract development and manufacturing organisation with a...
Strides sells arm’s manufacturing unit to Syngene International for Rs 702 crore
Strides Pharma Science on Monday said it has entered into a binding agreement to sell biologics Unit-3 manufacturing facility of its associate company Stelis Biopharma (SBL) to Syngene International on a slump sale...
Thermo Fisher, Celltrion vie for Baxter’s biopharma unit -sources
U.S. scientific instruments maker Thermo Fisher Scientific Inc and South Korea’s Celltrion Inc are among those competing to acquire the biopharma solutions business of medical device maker Baxter International...